Toronto Lymphoma Conference 2023

November 3, 2023 • Toronto, ON

Conference Objectives

  • Provide current and high-quality information on the latest developments in the management of lymphoproliferative disease
  • Create collegial learning opportunities to enable clinicians to share real-world experience and to directly apply new insights to their practice
  • Foster discussions that allow for the sharing of knowledge and experience among delegates and industry representatives
  • Respond to emerging professional needs for specific and in-depth information on the latest therapies for lymphoproliferative disease in the Canadian market

Scientific Steering Committee

John Kuruvilla, MD, FRCPC

John Kuruvilla, MD, FRCPC

Peter Anglin, MD, MBA, FRCPC

Peter Anglin, MD, MBA, FRCPC

Conference Agenda




7:00 AM

Breakfast (60 mins)

8:00 AM

Introduction & Welcome

Dr. John Kuruvilla & Dr. Peter Anglin

8:10 AM

What is the SOC for POD24 FL

Dr. Dai Chihara
MD Anderson Cancer Center

8:30 AM

BiTEs and CARTs in RR-FL

Dr. Ronan Foley
McMaster University

8:50 AM


9:05 AM

Overview of the Treatment of PTCL-NOS

Dr. Matthew Lunning
University of Nebraska Medical Center

9:25 AM

Management of Rare PTCL Subtypes

Dr. Anca Prica
Princess Margaret Cancer Centre

9:45 AM


10:00 AM

Health Break (15 mins)

10:15 AM

Evolving Primary Therapy Approaches in DLBCL

Dr. Jason Westin
MD Anderson Cancer Center

10:35 AM

What is new in CART for DLBCL

Dr. Jakub Svoboda
University of Pennsylvania

10:55 AM

Bispecific Antibodies in RR-DLBCL

Dr. Krish Patel
Swedish First Hill Hospital, Seattle, WA

11:15 AM


11:30 AM

Lunch (60 mins)

12:30 PM

The Shifting Sands of Primary Treatment of Advanced cHL

Dr. Ann LaCasce
Dana-Farber Cancer Institute

12:50 PM

Optimizing Treatment of RR-cHL

Dr. Michael Crump
Princess Margaret Cancer Centre

1:10 PM


1:25 PM

The Evolution of Primary Treatment in MCL

Dr. John Kuruvilla
Princess Margaret Cancer Centre

1:45 PM

Positioning Novel Therapy in RR-MCL

Dr. Kami Maddocks
Ohio State University Comprehensive Cancer Center

2:05 PM


2:20 PM

Health Break (15 mins)

2:35 PM

CLL Frontline Therapy: Fixed Duration vs. Treat to Progression

Dr. Abi Vijenthira
Princess Margaret Cancer Centre

2:55 PM

How to treat CLL after BTKi and BCL2i

Dr. Versha Banerji
CancerCare Manitoba

3:15 PM

Richter’s Syndrome: State-of-the-Art Management

Dr. Tanya Siddiqi
City of Hope National Medical Center, Duarte, CA

3:30 PM


3:45 PM

Closing Remarks

Dr. John Kuruvilla & Dr. Peter Anglin

4:00 PM


Our Sponsors


Canadian Hematology Today provides a forum for the clinical community to share real-world experience and the latest best practices in the treatment and management of hematologic disease.

The journal is published thrice yearly in English and French and is circulated to over 1,100 hematology clinicians and researchers across Canada. It features peer-reviewed articles that present robust clinical perspectives and practical insights into disease management.